SEC Filing · 6-K
Regencell Bioscience Holdings Limited
RGCNASDAQEQUITYCurrent
SEC Filing
Company context
We are an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. Our goal is to save and improve the lives of the patients, their families and caregivers and become a market leader for natural and holistic treatments for neurological disorders globally.
Current securities
As-filed source
As filedOpen full document ↗